Skip to main content

Table 1 Difference of clinical features between HCC patients at low and high stages of TNM (AJCC).

From: Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma

Variables Mean Rank P
  Stage Low Stage High  
Platelet ×109/L 16.77 23.00 0.034
Thrombocytocrit % 17.19 21.90 0.027
Cystatin C mg/L 16.08 24.80 0.003
Albumin/Globin 16.38 24.00 0.032
High density lipoprotein mmol/L 15.88 25.30 0.001
α-fetoprotein ng/ml 16.46 23.80 0.046
Ferritin ng/ml 15.62 26.00 0.004
Numbers of up-regulated tumor markers 15.48 26.35 0.003
Multiple Satellite nodules 16.77 23.00 0.053
Tumor encapsulation 16.88 22.70 0.022
score of Pathology section 15.58 26.10 0.007
Score of Tumor markers 16.35 24.10 0.042
Total score 16.27 24.30 0.040
  1. Stage low: TNM (AJCC) stage I. Stage high: TNM (AJCC) stage II-IV.
  2. HCC: Hepatocellular carcinoma; TNM (AJCC): Tumor-Node-Metastasis Staging System (American Joint Committee on Cancer).